Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

Market Cap	19.12B +136.9%
Revenue (ttm)	3.00B +26.5%
Net Income	245.26M -0.8%
EPS	1.15 -2.5%
Shares Out	212.10M
PE Ratio	78.38
Forward PE	56.34
Dividend	0.23 (0.26%)
Ex-Dividend Date	n/a

Volume	14,031,177
Open	90.16
Previous Close	90.15
Day's Range	89.11 - 99.97
52-Week Range	42.80 - 98.88
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 4,195
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688131

Financial Performance

In 2025, SHA:688131's revenue was 2.88 billion, an increase of 26.73% compared to the previous year's 2.27 billion. Earnings were 239.81 million, an increase of 18.96%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 29, 2026

Data Sources Report a data error